Prot #A4091064: A Phase 3, Multicenter, Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement

Project: Research project

Project Details

StatusFinished
Effective start/end date9/11/15 → 9/11/19

Funding

  • inVentiv Health Clinical (Prot #A4091064 // Prot #A4091064)
  • Pfizer Inc. (Prot #A4091064 // Prot #A4091064)